DOSE-FINDING STUDY TO ASSESS THE SAFETY AND EFFECT OF SYL1001 IN PATIENTS WITH OCULAR PAIN

Trial Profile

DOSE-FINDING STUDY TO ASSESS THE SAFETY AND EFFECT OF SYL1001 IN PATIENTS WITH OCULAR PAIN

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs Tivanisiran (Primary)
  • Indications Ocular pain
  • Focus Therapeutic Use
  • Sponsors Sylentis
  • Most Recent Events

    • 04 Apr 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 14 Mar 2016 Results and additional analysis of this clinical trial will be presented at the ARVO conference in May 2016, according to a Sylentis media release.
    • 14 Mar 2016 Results published in a Sylentis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top